iShares Nasdaq US Biotechnology UCITS ETF - USD Stock

ETF

BTEK

IE00BYXG2H39

OTC Markets Traded

Market Closed - London S.E. 11:35:12 2026-10-05 EDT			5-day change	1st Jan Change
10.13 ^USD	-0.20%		-1.70%	+21.94%

08-20	Will Moderna Wake Up the Health Care Sector?
06-11	IShares IV Public Limited Company Announces Interim Distribution for 2026, Payable on 30 June 2026	CI

Chart: iShares Nasdaq US Biotechnology UCITS ETF - USD

London S.E.USD

Markets		Quality
London S.E.	BTEK	Delayed
Xetra	2B70	Delayed
Swiss Exchange	BTEC	Delayed
London S.E.	BTEK	Delayed
Tradegate	2B70	Real-time
Boerse Muenchen	2B70	Real-time
CBOE	BTEK	Real-time
Swiss Exchange	BTEC	Delayed
Börse Stuttgart	2B70	Delayed
Swiss Exchange	BTEC	Delayed
CBOE	BTEK	Real-time
CBOE	BTEK	Real-time
Deutsche Boerse AG	2B70	Delayed
CBOE		Real-time

Dynamic Chart

Investment objective

The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.

Composition of iShares Nasdaq US Biotechnology UCITS ETF - USD

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Off-Hours Price	Change	YTD change	Weight
GILEAD SCIENCES, INC.	144.63USD	-0.08%	+17.83%	9.34%
VERTEX PHARMACEUTICALS INCORPORATED	503.50USD	-0.24%	+11.06%	9.05%
AMGEN INC.	402.98USD	-0.01%	+23.12%	8.97%
REGENERON PHARMACEUTICALS, INC.	726.47USD	-1.19%	-5.88%	5.98%
ALNYLAM PHARMACEUTICALS, INC.	219.89USD	+0.08%	-44.70%	3.29%
INSMED INCORPORATED	103.83USD	-6.56%	-40.34%	2.4%
BIOGEN INC.	223.59USD	+1.69%	+27.05%	2.07%
UNITED THERAPEUTICS CORPORATION	536.40USD	-0.98%	+10.09%	1.63%
MODERNA, INC.	203.21USD	+6.95%	+589.08%	1.52%

See all (251)

All the latest ETF news

10-05	'Spaghetti Cannon' Of ETFs: Corgi's Weniger	MT
10-05	If the bank behind your ETF goes bust, what happens to your money?
10-05	ROI-Wall Street bulls try on 'S&P 10,000' caps for size: McGeever	RE
10-05	CIBC and CIBC Global Asset Management Expand Access to Existing ETF Strategies with Three New Mutual Funds	CI
10-05	Tokyo-listed Brazilian stock exchange traded fund rises more than 12%	RE
10-02	US-listed ETFs on course for record annual inflows, State Street says	RE
10-02	US equity funds post second weekly inflow as AI optimism tempers yield concerns	RE
10-02	Global equity funds draw inflows for second week as AI optimism holds	RE

More news

In partnership with

Quotes

Date	Price	Change	Volume
26-10-05	US$10.13	-0.20%	166,414
26-10-02	US$10.15	-1.26%	253,037
26-10-01	US$10.28	-1.72%	421,407
26-09-30	US$10.46	+1.55%	186,211
26-09-29	US$10.30	-0.05%	181,002

Delayed Quote London S.E.

More quotes

Description

	IE00BYXG2H39
Total Expense Ratio	0.0035
Asset Class	Stocks
Geographical Zones	Americas
Sector	Biotechnology Pharmaceuticals
Currency	USD
Provider	iShares
Underlying	NASDAQ Biotechnology Net Total Return Index - USD
Autres ETFs